Table 2 Univariate and multivariate survival analyses including age, sex, UICC stage, CD4 positive infiltration and activin state
From: Prognostic impact of activin subunit inhibin beta A in gastric and esophageal adenocarcinomas
Clinical Factor | Univariate | Multiple Cox Regression | ||||
|---|---|---|---|---|---|---|
Mean Survival | CI | p | HR | CI | p | |
Total patients | 57.79 | 49.7–65.8.86 | ||||
Age | ||||||
≤ 65 years | 64.66 | 53.39–75.92 | 0.028 | 1.409 | 1.039–1.911 | 0.027 |
> 65 years | 47.39 | 36.86–57.88 | ||||
Sex | ||||||
Female | 60.54 | 46.93–74.12 | 0.629 | 0.838 | 0.616–1.139 | 0.258 |
Male | 54.34 | 44.74–63.94 | ||||
UICC stage | ||||||
UICC I | 113.52 | 96.68–130.34 | < 0.001 | 2.332 | 1.985–2.740 | < 0.001 |
UICC II | 73.05 | 57.85–88.26 | ||||
UICC III | 22.44 | 14.97–29.91 | ||||
UICC IV | 11.85 | 9.23–14.473 | ||||
Ming | ||||||
Expansive | 63.55 | 51.51–75.69 | 0.033 | 1.122 | 0.814–1.547 | 0.482 |
Infiltrative | 49.79 | 39.84–59.74 | ||||
CD4 | 0.988 | 0.717–1.362 | 0.943 | |||
High | 70.34 | 55.35–85.34 | 0.017 | |||
Low | 49.02 | 38.97–59.06 | ||||
Activin | 0.866 | 0.594–1.262 | 0.454 | |||
High | 72.13 | 55.92–88.34 | 0.014 | |||
Low | 51.28 | 42.35–60.20 | ||||